NDC Package 67296-1702-4 Clindamycin Hydrochloride

View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

67296-1702-4

Package Description:

40 CAPSULE in 1 BOTTLE

Product Code:

67296-1702

Proprietary Name:

Clindamycin Hydrochloride

Usage Information:

Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING, before selecting clindamycin, the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Serious respiratory tract infections such as empyema, anaerobic pneumonitis, and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection. Streptococci: Serious respiratory tract infections; serious skin and soft tissue infections. Staphylococci: Serious respiratory tract infections; serious skin and soft tissue infections. Pneumococci: Serious respiratory tract infections. Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin.To reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin hydrochloride capsules USP and other antibacterial drugs, clindamycin hydrochloride capsules USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

11-Digit NDC Billing Format:

67296170204

NDC to RxNorm Crosswalk:

RxCUI: 197518 - clindamycin HCl 150 MG Oral Capsule

RxCUI: 197518 - clindamycin 150 MG Oral Capsule

RxCUI: 197518 - clindamycin (as clindamycin HCl) 150 MG Oral Capsule

Labeler Name:

Redpharm Drug, Inc.

Sample Package:

Start Marketing Date:

11-01-2019

Listing Expiration Date:

12-31-2023

Exclude Flag:

Code Structure:

67296 - Redpharm Drug, Inc.
- 67296-1702 - Clindamycin Hydrochloride
  - 67296-1702-4 - 40 CAPSULE in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
67296-1702-3	30 CAPSULE in 1 BOTTLE
67296-1702-6	60 CAPSULE in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 67296-1702-4?

The NDC Packaged Code 67296-1702-4 is assigned to a package of 40 capsule in 1 bottle of Clindamycin Hydrochloride, labeled by Redpharm Drug, Inc.. The product's dosage form is and is administered via form.

Is NDC 67296-1702 included in the NDC Directory?

No, Clindamycin Hydrochloride with product code 67296-1702 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Redpharm Drug, Inc. on November 01, 2019 and its listing in the NDC Directory is set to expire on December 31, 2023 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 67296-1702-4?

The 11-digit format is 67296170204. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-4-1	67296-1702-4	5-4-2	67296-1702-04

Table of Contents